Professur für Organische Chemie

Friedrich-Alexander-Universität Erlangen-Nürnberg
Naturwissenschaftliche Fakultät
Department Chemie und Pharmazie
Lehrstuhl für Organische Chemie II
close-button

Project Types

Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third party funded individual grant
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project

Status

Project year

From
To
Krebsspezifische Fe(II)-Clathrochelat-Prodrugs zur gezielten Behandlung von fortgeschrittenem Lungenkrebs April 1, 2026 - March 31, 2029 N-Dialkylaminoferrocene-Prodrugs Targeting Lysosomes in Cancer Cells (LysoCene) April 1, 2026 - March 31, 2029 Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. (NeutroCure) Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. Jan. 1, 2020 - Dec. 31, 2024 Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging Jan. 1, 2020 - Dec. 31, 2023 Chiroptical, optical and magnetic probes for protein sensing based on cage metal complexes (CLATHROPROBES) Jan. 1, 2018 - Dec. 31, 2023 Krebs-spezifische N-alkylaminoferrocen-basierte Prodrugs Dec. 1, 2019 - Nov. 30, 2022